Project Details
Description
A Phase II Trial of Bevacizumab in Combination with First- or Second-Line Therapy in Subjects with Treated Brain Metastases due to Non-Squamous Non-Small Cell Lung Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 5/18/07 → 1/20/11 |
Funding
- GENENTECH, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.